Long-Term Stimulant Medication Treatment of Attention-Deficit/Hyperactivity Disorder
- 1 February 2006
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Developmental & Behavioral Pediatrics
- Vol. 27 (1), 1-10
- https://doi.org/10.1097/00004703-200602000-00001
Abstract
The purpose of this study was to offer detailed information about stimulant medication treatment provided throughout childhood to 379 children with research-identified attention-deficit hyperactivity disorder (ADHD) in the 1976-1982 Rochester, MN, birth cohort. Subjects were retrospectively followed from birth until a mean of 17.2 years of age. The complete medical record of each subject was reviewed. The history and results of each episode of stimulant treatment were compared by gender, DSM-IV subtype of ADHD, and type of stimulant medication. Overall, 77.8% of subjects were treated with stimulants. Boys were 1.8 times more likely than girls to be treated. The median age at initiation (9.8 years), median duration of treatment (33.8 months), and likelihood of developing at least one side effect (22.3%) were not significantly different by gender. Overall, 73.1% of episodes of stimulant treatment were associated with a favorable response. The likelihood of a favorable response was comparable for boys and girls. Treatment was initiated earlier for children with either ADHD combined type or ADHD hyperactive-impulsive type than for children with ADHD predominantly inattentive type and duration of treatment was longer for ADHD combined type. There was no association between DSM-IV subtype and likelihood of a favorable response or of side effects. Dextroamphetamine and methylphenidate were equally likely to be associated with a favorable response, but dextroamphetamine was more likely to be associated with side effects. These results demonstrate that the effectiveness of stimulant medication treatment of ADHD provided throughout childhood is comparable to the efficacy of stimulant treatment demonstrated in clinical trials.Keywords
This publication has 29 references indexed in Scilit:
- Case Definition in Epidemiologic Studies of AD/HDAnnals of Epidemiology, 2005
- National Institute of Mental Health Multimodal Treatment Study of ADHD Follow-up: Changes in Effectiveness and Growth After the End of TreatmentPublished by American Academy of Pediatrics (AAP) ,2004
- Is Attention Deficit Hyperactivity Disorder Increasing Among Girls in the US?CNS Drugs, 2002
- Methylphenidate: Its Pharmacology and UsesMayo Clinic Proceedings, 2000
- Clinical Practice Guideline: Diagnosis and Evaluation of the Child With Attention-Deficit/Hyperactivity DisorderPediatrics, 2000
- Methyiphenidate vs. amphetamine: Comparative reviewJournal of Attention Disorders, 2000
- Pharmacoeconomic evaluation of new treatments: efficacy versus effectiveness studies?Annals Of The Rheumatic Diseases, 1999
- Potential Influence of Migration Bias in Birth Cohort StudiesMayo Clinic Proceedings, 1998
- History of the Rochester Epidemiology ProjectMayo Clinic Proceedings, 1996
- More Frequent Diagnosis of Attention Deficit–Hyperactivity DisorderNew England Journal of Medicine, 1995